BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 5, 2003
View Archived Issues
Epimmune Trimming Staff, Costs To Help Develop Pipeline Drugs
Epimmune Inc. reduced its staff by 23 percent and implemented other cost-cutting measures that the company said would give it enough operating funds to pull results from ongoing clinical trials in HIV and cancer. (BioWorld Today)
Read More
Theratechnologies Enters Deal With J&J In Area Of Diabetes
Read More
Vaccine Spurs Immune System To Attack B. anthracis Plus Its Toxins, Beating Current Vaccines
Read More
Pozen Licenses MT 300 Rights To Xcel In Deal Worth At Least $10M
Read More
Cerus, Baxter Stop Phase III Of S-303 In Precautionary Move
Read More
Other News To Note
Read More